Sex differences in adverse events from systemic treatments for psoriasis: A decade of insights from the Swiss Psoriasis Registry (SDNTT).

Publication

Sex differences in adverse events from systemic treatments for psoriasis: A decade of insights from the Swiss Psoriasis Registry (SDNTT).

Journal Paper/Review - Dec 12, 2023

Verardi Fabio, Maul Lara Valeska, Borsky Kim, Steinmann Simona, Rosset Nina, Pons Hector Ortega, Sorbe Christina, Yawalkar Nikhil, Micheroli Raphael, Egeberg Alexander, Thyssen Jacob P, Heidemeyer Kristine, Boehncke Wolf-Henning, Conrad Curdin, Cozzio Antonio, Pinter Andreas, Kündig Thomas M, Navarini Alexander A, Maul Julia-Tatjana

Citation

Verardi F, Maul L, Borsky K, Steinmann S, Rosset N, Pons H, Sorbe C, Yawalkar N, Micheroli R, Egeberg A, Thyssen J, Heidemeyer K, Boehncke W, Conrad C, Cozzio A, Pinter A, Kündig T, Navarini A, Maul J. Sex differences in adverse events from systemic treatments for psoriasis: A decade of insights from the Swiss Psoriasis Registry (SDNTT). J Eur Acad Dermatol Venereol 2023

Type

Journal Paper/Review (English)

Journal

J Eur Acad Dermatol Venereol 2023

Publication Date

Dec 12, 2023

Issn Electronic

1468-3083

Brief description/objective

Psoriasis is a disease that often requires prolonged systemic treatment. It is important to determine the safety of available therapies. There is currently little insight into sex-specific differences in the safety of systemic psoriasis therapies.